RSV in adult ED patients: Do emergency providers consider RSV as an admission diagnosis?

American Journal of Emergency Medicine

Volumn 35, Issue 8, 2017, Pages 1162-1165

  Binder, William ^a   Thorsen, Jill ^b   Borczuk, Pierre ^b  

^a BROWN UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Influenza like illness; Respiratory infections; Respiratory syncytial virus; RSV

Indexed keywords

STEROID; ANTIVIRUS AGENT;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIFFERENTIAL DIAGNOSIS; EMERGENCY WARD; FEMALE; FEVER; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASM; MORTALITY; NONHUMAN; NOSE SMEAR; OBSERVATIONAL STUDY; OXYGEN SATURATION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RETROSPECTIVE STUDY; TRANSPLANTATION; WHEEZING; CLINICAL PRACTICE; HOSPITAL EMERGENCY SERVICE; HOSPITALIZATION; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; PRACTICE GUIDELINE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; STATISTICS AND NUMERICAL DATA; UNITED STATES; UTILIZATION; UTILIZATION REVIEW; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; DIAGNOSIS, DIFFERENTIAL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; UNITED STATES; UTILIZATION REVIEW; YOUNG ADULT;

EID: 85020544789     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2017.06.022     Document Type: Article

References (23)

1. Meng, J., Stobart, C.C., Hotard, A.L., Moore, M.L., An overview of respiratory syncytial virus. PLoS Pathog, 2014, e1004016, 10.1371/journal.ppat.100.
2. Haynes, A.K., Prill, M.M., Iwane, M.K., Gerber, S.I., Respiratory syncytial virus—United States, July 2012–June 2014. MMWR 63 (2014), 1133–1136.
3. Hall, C.B., Weinberg, G.A., Iwane, M.K., et al. The burden of respiratory syncytial virus infection in young children. NEJM 360 (2009), 588–598.
4. Byington, C.L., Wilkes, J., Korgenski, K., Xiaoming, S., Respiratory syncytial virus-associated mortality in hospitalized infants in young children. Pediatrics 135 (2015), e24–e31.
5. Nair, H., Nokes, D.J., Gessner, B.D., Dherani, M., Madhi, S.A., et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375 (2010), 1545–1555.
6. Wong, T.M., Boyapalle, S., Sampayo, V., Nguyen, H.D., Bedi, R., et al. Respiratory syncytial virus (RSV) infection in elderly mice results in altered antiviral gene expression and enhanced pathology. PLoS One, 9, 2014, e88764.
7. Guichelaar, T., Hoeboer, J., Widjojoatmodjo, M.N., Reemers, S.S.N., van Els, C.A.C.M., Otten, R., et al. Impaired immune response to vaccination against infection with human respiratory syncytial virus at advanced age. J Virol 88 (2014), 9744–9750.
8. Falsey, A.R., Hennessey, P.A., Formica, M.A., Cox, C., Walsh, E.E., Respiratory syncytial virus infection in elderly and high-risk adults. NEJM 352 (2005), 1749–1759.
9. Falsey, A.R.C.C., Barker, W.H., et al. Respiratory syncytial virus and influenza a infections in the hospitalized elderly. J Infect Dis 172 (1995), 389–394.
10. Murata, Y., Respiratory syncytial virus infection in adults. Curr Opin Pulm Med 14 (2008), 235–240.
11. Sundaram, M.E., Meece, J.K., Sifakis, F., Gasser, R.A., Belongia, E.A., Medically attended respiratory syncytial virus infections in adults aged greater than 50 years. Clin Infect Dis 58 (2014), 342–349.
12. Mullooly, J.P., Bridges, C.B., Thompson, W.W., et al. Influenza and RSV associated hospitalizations among adults. Vaccine 25 (2007), 846–855.
13. Falsey, A.R., Walsh, E.E., Respiratory syncytial virus infection in elderly adults. Drugs Aging 22 (2005), 577–587.
14. Lee, N., Lui, G.C.Y., Wong, K.T., Li, T.C.M., et al. High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin Infect Dis 57 (2013), 1069–1077.
15. Johnstone, J., Majumdar, S.R., Fox, J.D., Marrie, T.J., Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation. Chest 134 (2008), 1141–1148.
16. Van Asten, L., van den Wijngaard, C., van Pelt, W., et al. Mortality attributable to 9 common infections: significant effect of influenza a, respiratory syncytial virus, influenza B, norovirus and parainfluenza in elderly persons. J Infect Dis 206 (2012), 628–639.
17. Matias, G., Taylor, R., Haguinet, F., Schuck Paim, C., Lustig, R., Shinde, V., Estimates of Mortality Attributable to Influenza and RSV in the United States during 1997–2009 by Influenza Type or Subtype, Age, Cause of Death, and Risk Status. Influenza and Other Respiratory Viruses. 8, 2014, 507–515.
18. Widmer, K., Griffin, M.R., Zhu, Y., Williams, J.V., Talbot, H.K., Respiratory syncytial virus-and human metapneumovirus-associated emergency department and hospital burden in adults. Influenza Other Respi Viruses 8 (2014), 347–352.
19. Camargo, C.A., Ginde, A.A., Clark, S., Cartwright, C.P., Falsey, A.R., Niewoehner, D.E., Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease. Intern Emerg Med 3 (2008), 355–359.
20. French, C.E., McKenzie, B.C., Coope, C., Rajanaidu, S., Paranthaman, K., et al. Risk of nosocomial respiratory syncytial virus infection and effectiveness of control measures to prevent transmission events: a systematic review. Influenza Other Respi Viruses 10 (2016), 268–290.
21. Waghmare, A., Campbell, A.P., Hu, X., Seo, S., et al. Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes. Clin Infect Dis 57 (2013), 1731–1741.
22. Marcelin, J.R., Wilson, J.W., Razonable, R.R., Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients. Transpl Infect Dis 16 (2014), 242–250.
23. Simoes, E.A.F., DeVincenzo, J.P., Boeckh, M., Bont, L., et al. Challenges and opportunities in developing respiratory syncytial virus therapeutics. J Infect Dis 211:S1 (2015), S1–20.